Schedule 13D ownership disclosure

SELLAS Life Sciences Group, Inc.

Security class unavailable · CUSIP: 81642T100

Event date: 2017-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
50.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-005829
Form type
SC 13D
Filer
Equilibria Capital Management Ltd
CIK
CIK 1724701
Filed
Jan 08, 2018
Reporting period
Dec 29, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub